v3.26.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenues
Operating expense:        
General and administrative 555,192 350,577 1,227,185 1,119,809
Research and development 826,453 485,677 1,642,564 1,307,853
Gain on extinguishment of accounts payable 97,500
Total operating expenses 1,381,645 836,254 2,772,249 2,427,662
Loss from operations: (1,381,645) (836,254) (2,772,249) (2,427,662)
Other (income) expense:        
Grants income (420,030) (865,000)
Interest expense - related parties 3,623 6,323 27,615 24,470
Total other (income) expense 3,623 (413,707) 27,615 (840,530)
Income (Loss) before provisions for income taxes (1,385,268) (422,547) (2,799,864) (1,587,132)
Provisions for income taxes
Net Income (Loss): $ (1,385,268) $ (422,547) $ (2,799,864) $ (1,587,132)
Net income (loss) per basic share $ (0.004) $ (0.001) $ (0.009) $ (0.005)
Net income (loss) per share, fully diluted $ (0.004) $ (0.001) $ (0.009) $ (0.005)
Weighted average common shares outstanding        
Weighted average common shares outstanding - Basic 324,063,545   320,658,983 310,842,369
Weighted average common shares outstanding - Diluted 324,063,545 312,167,546 320,658,983 310,842,369